China’s Drug Evaluation Authority Issues Draft Rules for Class I ATMP Meetings
The Center for Drug Evaluation (CDE), part of China’s National Medical Products Administration (NMPA), published...
CMDE
NMPA Seeks Comments on Medical Device Classification Draft Proposal
The National Medical Products Administration (NMPA) has issued a notification focusing on the definition and...
Beijing Balance Medical’s Transcatheter Valve System Enters China’s Innovative Device Review
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that its transcatheter valve...
Galvanize Therapeutics Partners with Energenx Medical for Greater China Expansion
US-based Galvanize Therapeutics Inc. has revealed a licensing deal with Shanghai-based Energenx Medical Ltd, which...
China’s First Proton Therapy System Approved by NMPA
The National Medical Products Administration (NMPA) has approved the proton therapy system developed by Shanghai...
Venus Medtech’s Transcatheter Prosthetic Pulmonary Valve Approved by NMPA
The National Medical Products Administration (NMPA) has approved Venus Medtech (Hangzhou) Inc’s (HKG: 2500) transcatheter...